A stem cell describes a self-renewing, primitive, undifferentiated, multipotent source of multiple cell lineages. Such cells are critical for development and growth; pools of adult stem cells are hypothetical sources for tissue regeneration and repair as well as cancers. In contrast to embryonic stem cells and tumor cells, adult stem cells reduce telomere length with age (
Warburton et al., 2008).
In the lung, there is limited knowledge about existence of self-renewing cells, whether such cells conform to classic or nonclassic stem cell hierarchies and whether a single stem/progenitor cell suffices to generate the more than 40 distinct cell types required in mature lung. At least five putative epithelial stem/progenitor cell niches are reported in adult mouse airway (
Liu and Engelhardt, 2008), as well as endothelial stem cells in the pulmonary vasculature and ASM stem cells. Additionally, circulating stem/progenitors may lodge in the lung. Unlike skin and gastrointestinal tract, postnatal lung turns over slowly, which hampers putative progenitor identification. Specific markers and clonality assays also limit attempts at isolation. Herein we review new information regarding the development and function of lung stem/progenitor cells in organogenesis.
5.1. Endogenous epithelial progenitor cells
Failing regeneration and repair with age has been suggested to be due to stem cell failure. In pseudoglandular lung, tips of the branching tubules appear to contain undifferentiated multipotent epithelial progenitors. In adult lung, putative endogenous epithelial progenitors have been located in the basal layer of the upper airways, within or near pulmonary neuroendocrine cell rests as well as at the bronchoalveolar junction and in the alveolar epithelium (
Engelhardt, 2001;
Giangreco et al., 2002,
2004;
Kim et al., 2005;
Rawlins and Hogan 2006;
Reddy et al., 2004;
Reynolds et al., 2000,
2004). The distal-most epithelial cells were shown to be a multi-potent progenitor cell population during branching morphogenesis of the lung (
Rawlins et al., 2009a). A recent model suggests, as the lung branches, descendents of distal tip progenitors are left to differentiate in the stalks, whereas self-renewing progenitors remain in the epithelial tips: distal epithelial cells have a unique gene expressionpattern, including high levels of
Sox 9, Id2 (inhibitor of differentiation 2),
N-myc, and
Etv5/ERM (ets variant gene 5). In addition, they are exposed to high levels of FGF, Wnt, Shh, and BMP signaling (
Bellusci et al., 1996;
Liu et al., 2002;
Shu et al., 2005). Many of these pathways including
sox9, etv5, and FGFR signaling are associated with stem/progenitor cells in other endodermally derived organs (
Seymour et al., 2007;
Zhou et al., 2007). Distal epithelial cells also have different cell cycle kinetics compared with the rest of the epithelium; a higher proportion of them incorporate the thymidine analog bromodeoxyuridine (BrdU) during a short pulse (
Okubo et al., 2005).
5.1.1. Tracheal and bronchial epithelial progenitors Candidate endogenous stem or progenitor cells have been identified in trachea and lung, using lung injury/repair models. For example, CC10/
Scgb1a1+ Clara cells self-renew and proliferate after tracheal injury, but seem not the main source for tracheal epithelial regeneration (
Rawlins et al., 2009b). However, subsets of Keratin-14 (K-14)-expressing BCs in the trachea (
Hong et al., 2004a) can restore differentiated epithelium after injury and are distinct from bronchial BCs (
Hong et al., 2004b). Lineage tracing in the adult mouse lung and trachea showed K-14-positive cells act as progenitors and ciliated cells cannot (
Hong, et al., 2004a;
Rawlins, et al., 2007). Human
SpC and rat
CC10 promoters have also been used for lineage tracing in lung (
Perl et al., 2002,
2005a).
Since pseudostratified epithelium of mouse trachea and human airways contains a BC population expressing cytokeratin 5 (
Krt5), a recent study using
Krt5-CreERT2 transgenic mouse line for lineage tracing showed BCs of mouse trachea function as progenitors during postnatal growth, in adult homeostasis and also in epithelial repair of experimentally-induced SO
2 damage (
Rock et al., 2009). A clonality assay also found BCs of mouse and human airways self-renew and differentiate into mucus and ciliated lineages in the absence of stroma or columnar epithelial cells.
There is also a rare mixed population of pluripotent cells in lower respiratory tract characterized as a Hoechst dye effluxing side population (SP) cells. They express molecular markers of airway and mesenchymal origin (
Giangreco et al., 2004). CD45
− SP cells isolated from human tracheobronchial epithelium have proliferative potential. Increased numbers of these cells in asthmatic airways suggest that dysregulation of pluripotent cells may play a role in this chronic disorder (
Hackett et al., 2008). In developing lung, some SP cells, which are CD45
+ and CD45
− have endothelial progenitor cell (EPC) potential in response to hyperoxia (
Irwin et al., 2007).
The submucosal gland ducts in proximal airway are likewise suspected to contain stem cells (
Liu and Engelhardt, 2008). However, relatively little is known about glandular stem/progenitor cells and their niche(s). Studies have suggested regenerating tracheal epithelium after naphthalene injury arises from cells migrating from gland ducts (
Borthwick et al., 2001).
Rawlins et al. (2009b) used lineage tracing to circumvent obstacles that hampered earlier studies of lung stem/progenitor cells. Using the restricted expression of
CC10/
Scgb1a1, they generated a “knocking” transgenic mouse with a tamoxifen (TM) inducible
Cre-recombinase (
ScgB1a1-CreER™) that lineage-tags Clara cells of the airway. By varying dose and timing of TM administration, they discovered that epithelial reconstitution in the bronchioles involves Clara cell self-renewal and differentiation into ciliated cells. These data argue that bronchiolar
ScgB1a1-expressing cells, largely mature Clara cells, are a self-renewing progenitor pool. The observation that lineage tags are chased into ciliated cells over time is consistent with early findings of Evans and colleagues (1978) that Clara cells are progenitors for ciliated cell renewal. On the other hand,
Rawlins et al. (2009b) showed that lineage tags introduced into
ScgB1a1-expressing cells of tracheobronchial airways were depleted within the
ScgB1a1-expressing population over time. Collectively, these data suggest that
ScgB1a1-expressing cells of proximal airways behave like transit amplifying (TA) cells, like those of intestinal epithelium, whereas
ScgB1a1 cells of bronchiolar airways behave like self-renewing progenitors present in the interfollicular epidermis (reviewed by
Chen et al., 2009).
A different approach by
Giangreco and colleagues (2009) to investigate long-term behavior of airway progenitors in normal and injured airways showed in concordance with
Rawlins et al. (2009b) that during homeostasis an abundant progenitor cell pool maintains the airway epithelium (rather than rare tissue stem cells). However, clonal patches of labeled cells emanate from tissue-specific stem cells located at airway branch points or bronchioalveolar duct junctions, after Clara cell depletion resulting from naphthalene exposure. In this naphthalene injury case, repairing bronchiolar airways more closely resemble the renewing epidermis after wounding, wherein stem cells are recruited from the hair follicle bulge to replace the depleted BC pool of the interfollicular epidermis (
Zemke et al., 2009).
Varying dose and timing of TM administration,
Rawlins et al. (2009a) discovered that reconstitution of bronchiolar epithelium involves Clara cell self-renewal and differentiation into ciliated cells and that Clara cells contribute to tracheal repair. Using lineage tracing, this study showed that a special population of BASCs which coexpress
CC10 and
SP-C, which have been proposed to contribute to both bronchioles and alveoli, has no apparent function during postnatal growth, adult homeostasis, or alveolar repair. Thus, they propose that trachea, bronchioles, and alveoli are maintained by distinct progenitor populations (
Rawlins et al., 2009a). Currently, the significance that some
Scgb1a1+ bronchiolar Clara cells express
SftpC and some alveolar type 2 cells express
Scgb1a1 is not understood. There is accumulating evidence the (
Scgb1a1+, SftpC+) coexpressing cell population increases in number in murine lung cancer models (
Ventura et al., 2007;
Yang et al., 2008). However, it is unclear if this is due to preferential proliferation of preexisting (
Scgb1a1+, SftpC+) cells or oncogenic upregulation of
SftpC or
Scgb1a1.
In a recent study (
Tompkins et al., 2009), selective
Sox2 deletion in Clara cells with
Scgb1a1-Cre showed that Clara cell Sox2 is required for differentiation and/or maintenance of ciliated, Clara, and goblet cells in bronchiolar epithelium after birth and caused progressive loss of ciliated, Clara, and goblet cells and an inability to produce goblet cells in response to allergen. The findings indicate Clara cells can serve as common progenitors of ciliated, Clara, and goblet cells in a process requiring
Sox2.
5.1.2. Alveolar epithelial progenitors Epithelial progenitors of the alveoli have yet to be identified. An interesting model is that the alveolar progenitors are located in distal epithelial tips during the canalicular stage. However, there is no published evidence to support, or refute, this hypothesis. Presumably, because of its vast area a large number of AECs must function as a “ready reserve” to repair damaged alveolar surface. For instance, the expression of telomerase, a stem/progenitor cell marker, after acute oxygen injury is widely upregulated in AECs during recovery (
Driscoll et al., 2000). This suggests that either AECs contain a progenitor cell subpopulation or that the majority of AECs undergo reactivation progenitor-like states after injury (
Driscoll et al., 2000). In addition, without telomerase, resistance to injury and repopulation of damaged alveoli are compromised, indicating this pathway is likely critical for alveolar progenitor cell activity (Driscoll
et al., personal communication). Moreover,
Kim and colleagues (2005) described BASCs, which possess stem cell characteristics, are resistant to naphthaline injury and proliferate after airway or alveolar injury. Such BASCs reside near bronchioalveolar junctions and coexpress both alveolar (SP-C) and airway (CC10) epithelial cell markers, as well as coexpressing Sca-1. They are capable of self-renewal and differentiation into Clara cells and alveolar cells, and are also multipotent in clonal assays. Moreover, studies by
Hong and coworkers (2001) identified variant Clara cells as endogenous lung stem cells, which infrequently proliferate during steady state but are held responsible for repopulating distal airway epithelium after injury. Variant Clara cells express Clara cell secretory protein, but survive naphthalene injury. As the lung continues to grow postnatally, Clara cells both self-renew and act as progenitors for ciliated cells, based on kinetics of cell labeling after a pulse of tritiated [3H]-thymidine (
McDowell et al., 1985;
Plopper, et al., 1992). This is supported by recent lineage labeling (
Perl et al., 2005a). Whether all Clara cells have this capacity requires investigation. Moreover, type II cells proliferate and give rise to type I cells after adult alveolar injury, and this probably also occurs during postnatal growth (
Evans et al., 1975). Several putative endogenous alveolar stem cell populations thus provide targets for directed regenerative therapies. Taking acute oxygen injury as an example, AECs undergo DNA and other forms of damage such as mitochondrial failure, glutathione depletion, and apoptosis (
Buckley et al., 1998;
Lee et al., 2006;
Roper et al., 2004).
5.2. Endogenous mesenchymal progenitors
5.2.1. Smooth muscle progenitors Distal
Fgf10-expressing mesenchymal cells serve as progenitors for peripheral ASM (
De Langhe et al., 2006;
Mailleux et al., 2005;
Ramasamy et al., 2007).
Fgf10-lacz lineage tracing reveals ASM progenitors begin as
Fgf10-expressing cells that, as the airway elongates, become distributed along peripheral airway. Transdifferentiation to express alpha–smooth muscle actin occurs under the control of SHH and BMP4, which are expressed proximal to the airway tip. Thus, increase in population size and localization of peripheral ASM progenitors occur early in development. Another population of ASM progenitors arise in proximal mesenchyme and advance peripherally (
Shan et al., 2008).
5.2.2. Vascular progenitors Lung microcirculation is rich in progenitors, but our understanding of these is limited. Mesothelium overlying the lung contains progenitors that give rise to pulmonary vascular (but not airway) SMCs during embryonic development (
Que et al. 2008). Endothelial progenitors arise from endogenous vascular wall or from circulating progenitors. Similar to lung epithelial cells, heterogenous pulmonary endothelial cells may require a site-specific niche (
Clark et al., 2008); alternatively, putative resident endothelial progenitors may constitute a universal pool of progenitors that lack segmental specification (
Blaisdell et al., 2009).
Distal airspace and vascular growth are coordinated so injury can affect both (
Jakkula et al., 2000).
Balasubramaniam et al. (2007) examined endothelial progenitors in BPD to show that hyperoxia disrupts alveolar and vascular growth, limiting surface area for gas exchange. In the lung, nitric oxide, VEGF, and erythropoietin contribute to mobilization and homing of EPCs. Several related developmental changes occur after hyperoxia in neonatal mice: expression of endothelial nitric oxide synthase, VEGF, and erythropoietin receptor and the number of EPCs in the blood, bone marrow, and lung were all reduced (
Balasubramaniam et al., 2007).
Primitive capillaries surround the laryngotracheal groove as the lung buds from foregut and can be visualized by β-galactosidase expression under control of Flk1 promoter. This promoter is active and the earliest known marker of hemangioblasts. Under stimulation of epithelial VEGF, these hemangioblasts differentiate into a capillary network that surrounds bronchial, lobar, and segmental airways (
Del Moral et al., 2006a;
Ramasamy et al., 2007). Organization of this plexus appears essential for correct branching and perfusion. Thus, mesothelial–mesenchymal–epithelial–endothelial crosstalk matches epithelial and vascular progenitor function and will likely be essential for lung regeneration to succeed. Further studies are needed to define phenotypes of the pulmonary endothelial cell but also SMCs within the vasculature (
Stevens et al., 2008).
5.3. Control of lung progenitor cell proliferation
Embryonic progenitors undergo symmetric and asymmetric divisions. To distinguish these, one can look at differences in spindle orientation or differential inheritance of cytoplasmic or membrane-bound proteins such as cell fate determinant Numb and atypical protein kinase C (PKC) (
Huttner and Kosodo, 2005;
Morrison and Kimble, 2006;
Wang et al., 2009; El-Hashash and Warburton, unpublished data). Cells divide asymmetrically in response to extrinsic or intrinsic fate determinants: extrinsically, daughter cells placed in different microenvironments adopt different fates; intrinsically, cytoplasmic cell fate determinants (e.g., Numb) are asymmetrically localized within a cell and segregate differentially into daughters that adopt different fates (reviewed by
Yamashita, 2009). Comparing progenitor numbers in mutant and sibling control lungs, we infer that certain molecules promote progenitor self-renewal or differentiation (
Rawlins, 2008).
Several transcription factors and signaling molecules control lung growth and therefore probably affect progenitor cell proliferation. Thyroid transcription factor 1 (Ttf-1/Nkx2.1) expression marks lung lineage commitment in the early embryo and is critical for distal lung progenitor development (
Kimura et al., 1999).
Ttf1−/−-null mice have insufficiently differentiated lungs for survival (
Kimura, et al., 1996). HMG box transcription factor,
Sox9 is intensively expressed in distal epithelial progenitors from E11.5 to E16.5 (
Liu and Hogan, 2002). However, lung-specific conditional deletion has no effect on progenitor cell behavior (
Perl et al., 2005b).
Sox9 may therefore act redundantly with other, as yet unknown, regulators: N-myc is also essential for maintaining a distal population of undifferentiated, proliferating progenitor cells, and may promote their self-renewal (
Okubo et al., 2005).
In addition, several forkhead/winged helix (fox) family transcription factors have mutant knockout phenotypes and may promote lung epithelial progenitor proliferation. For example, conditional deletion of both
foxa1 and f
oxa2 genes in lung results in small lungs with decreased cell division rates (
Wan et al., 2005). A similar phenotype was reported after conditional deletion of both
foxp1 and
foxp2, which are enriched in the distal epithelial progenitors. In
foxp22/2; foxp11/2 double mutants, the lungs are smaller than normal, with inhibited proliferation, but normal proximal–distal patterning (
Shu et al., 2007). This suggests an essential role of fox transcription factors in the maintenance of the progenitor cell population and their self-renewing divisions.
Similarly, five key signaling molecules regulate many processes in embryonic development: Wnt, Notch, Hedgehog, FGF, and TGF-β family. Embryos lacking Wnt2/2b exhibit lung agenesis and do not express Nkx2.1, the earliest marker of lung endoderm. Endoderm-restricted deletion of β-catenin replicates this, suggesting canonical Wnt2/2b signaling is required to specify lung endoderm progenitors in the foregut (
Goss et al., 2009,
Harris-Johnson, 2009). FGF signaling plays an essential role in specification of distal lung lineages (
De Langhe et al., 2008;
Ramasamy et al., 2007) and others (
Serls et al., 2005). FGF10 is expressed by lung mesenchyme and is a chemotaxin during morphogenesis. FGF10 overexpression maintains epithelial progenitor cell proliferation and leads to goblet cell metaplasia (
Nyeng et al., 2008). In addition, FGF10 coordinates alveolar SMC formation and vascular development (
Ramasamy et al., 2007). RA signaling is also essential for expansion of lung progenitors and formation of primary lung buds, by affecting
Fgf10 expression through TGF-β signaling (
Chen et al., 2007). Similarly, Shh in distal epithelium controls proliferation and branching and is believed to promote progenitor proliferation (
Pepicelli et al., 1998). Autocrine Bmp signaling is likewise important for proliferation of the distal epithelial progenitor cell compartment. Wnt5a is also highly expressed around distal epithelial tips.
Wnt5a−/− lungs have increased cell proliferation and an additional airway branch (
Li et al., 2002), but it is unknown if this phenotype relates to defective progenitors. The details of how these signaling pathways regulate distal epithelial progenitor cells remain to be determined.
5.4. Embryonic lung progenitors and proximal–distal patterning
Recent studies suggest that Wnt and Bmp signaling controls proximal–distal lung patterning, but there is currently no evidence to confirm that this is mediated through progenitors.
Shu et al. (2005) demonstrated that proximal–distal lung patterning depends on Wnt/β-catenin signaling and is mediated, in part, through regulation of N-myc, Bmp-4, and FGF signaling. Potentiation of β-catenin signaling in proximal airway results in arrested differentiation of immature bronchiolar stem cells, but β-catenin is unnecessary for adult bronchiolar stem cell maintenance (
Zemke et al., 2009). Fortunately, reporters of Wnt pathway activity are highly active in distal lung epithelial cells. Recent studies suggested that Wnt signaling regulates proximal–distal patterning and progenitor proliferation independently, and that Wnt promotes distal airway fate at the expense of the proximal. (
Mucenski et al., 2003;
Shu et al., 2005). Shu and coworkers overexpressed Dickkopf-1 to inhibit Wnt pathway activity throughout developing epithelium: this expands proximal (conducting) airways at the expense of the distal, without effects on total levels of cell proliferation (
Shu et al., 2005). Similarly,
Mucenski et al. (2003) showed that lung-specific deletion of β-catenin abrogates distal epithelial differentiation. Notch signaling favors progenitor identity at the expense of differentiated phenotypes in different organs (
Jadhav et al., 2006;
Mizutani et al., 2007) and is also required for lung epithelial progenitors. Notch1 is highly expressed in distal epithelial progenitors during the pseudoglandular stage (
Post et al., 2000). Notch controls cell fates in developing airways (
Tsao et al., 2009), and arrests normal differentiation of distal lung progenitors before they initiate an alveolar program (
Guseh et al., 2009). Notch misexpression in the distal lung prevented the differentiation of alveolar cell types (
Guseh et al., 2009); expression of a constitutively active form of Notch3 throughout the developing lung epithelium prevents cell differentiation (
Dang et al., 2003).
Furthermore, BMP signaling is also required for lung epithelium development, probably by promoting distal and repressing proximal cell fate. Inactivation of Bmp signaling by overexpression of a dominant-negative BMP receptor, or BMP antagonists Gremlin or Noggin, results in proximalization of lung epithelium (
Weaver et al., 1999;
Lu et al., 2001). Thus, reduction of BMP or Wnt signaling causes lung proximalization phenotypes (
Eblaghie et al., 2006;
Li et al., 2002).
5.5. Emergence of specific cell types during lung organogenesis
At least 40 differentiated cell types emerge during lung organogenesis. Early trachea and esophagus are both lined with ciliated epithelium; following their septation, esophageal epithelium becomes squamous, while tracheal epithelium retains cilia. Primitive airway epithelium expresses several marker proteins including cGRP, Clara cell protein, and SP-A: its differentiation starts around E16 in mouse with emergence of pulmonary neurendocrine (PNE) cell rests, surrounded shortly after by Clara cells. In the periphery, AEC2 differentiation in E18 mouse is denoted by glycogen granules’ disappearance and emergence of surfactant-containing lamellar bodies with increased SP-C expression.
In mature lung, epithelial lineages are arranged proximodistally along the airways. Cartilage lies outside the submucosa and decreases in amount as bronchial caliber decreases; it is absent from bronchioles. The two major epithelial cell types in proximal bronchi are pseudostratified ciliated columnar cells and mucous (goblet) cells. Both arise from BCs, but ciliated cells predominate. Goblet cells begin to mature around 13 weeks’ gestation in humans (mature ciliated columnar cells are already present), express mucin markers (MUC5B, 5A, 5C), and release mucus granules into the airway which reduces drying and, through ciliary-driven cephalad mucus flow, cleanses the airway. In cystic fibrosis, mutation of the cystic fibrosis transmembrane conductance regulator (
Cftr) gene disrupts expression of the encoded transmembrane Na
+ ion transporter protein leading to thick mucus that overwhelms ciliary clearance and increases susceptibility to infection. In chronic airway injury, goblet cell hyperplasia may follow repair or experimental epithelial IL-9 exposure; the latter increases epithelial lysozyme and mucus production (
Vermeer et al., 2003). IL-4, IL-13, and allergens enhance TGF-α release, which is a ligand for the EGFR that also stimulates goblet cell differentiation (
Lordan et al., 2002).
There are three types of cells in bronchial submucosal glands. Myoepithelial cells surround the gland, while mucous cells (pale cytoplasm) and serous cells (basophilic cytoplasm) produce mucins. These secreted mucins mix with lysozyme and IgA on airway surface.
Kulchitsky cells are also found next to bronchial glands, but their function is unclear. It is believed they are pulmonary neuroendocrine cells (PNECs) producing peptides such as serotonin and calcitonin. Their cytoplasmic extensions usually reach the airway lumen. Kulchitsky cells expressing gastrin-releasing peptide (GRP), calcitonin gene-related peptide (CGRP), and chromogranin may be related to small cell carcinoma and carcinoid tumors. However, PNEC differentiate earlier by 10 weeks’ human gestation and are the first fully differentiated murine airway epithelial cells.
Clara cells reside in distal bronchiolar airway epithelium (normally lacking mucous cells) and produce mucus-poor, watery secretion. They emerge during the 19th week in humans and appear to assist with clearance, detoxification, and surface tension reduction in small airways. Clara cell-specific protein (CC10, CCSP, or uteroglobin) and cytochrome P450 reductase CC10 can be used as Clara cell markers. Whilst normal mice feature few mucin-positive cells in the airway, mucus metaplasia is associated with numerous Clara cell-derived mucous cells with excess mucin production or reduced secretion (
Evans et al., 2004).
Most of the alveolar surface is covered by flat type I epithelial cells that are believed to be terminal differentiated and express several markers, such as T1a and aquaporin 5. T1a is developmentally regulated and encodes an apical membrane protein of unknown function. Absence of T1a protein blocks type I cell differentiation. Homozygous T1a null mice die at birth of respiratory failure with lungs that will not inflate normally (
Ramirez et al., 2003). Aquaporin 5 is a water-channel in type I epithelial cells. Recently, a knock in of Cre-ERT2 into the
Aqp5 locus has been reported (Borok, personal communication). These mice will be useful, not only to target gene deletion in type I cells but also for lineage tracing of the type I cells under development, injury, and repair.
Whilst type I epithelial cells cover more than 95% of the alveolar surface area, they account for only 40% of total AECs: the other 60% are rounded type II pneumocytes. These plump or cuboidal cells can regenerate and replace type I cells post injury and have finely stippled cytoplasm and surface microvilli. They manufacture surfactant phospholipids and proteins that modulate alveolar surface tension, such that despite varied size, alveoli remain open and end-expiratory atelectasis is reduced. Surfactant protein C (
SftpC) is a commonly used type II cell marker. The four surfactant proteins, SP-A, B, C, and D play critical roles: SP-A and SP-D participate in airway host defense; SP-B and SP-C contribute to surfactant’s surface tension reduction (
Whitsett et al., 2002).
Macrophages, although a small percentage of alveolar cells, are a major sentinel of host defense and derived primarily from blood monocytes; once in the lung, their turnover is extremely slow.
5.6. Stem and progenitor cells in the postnatal respiratory system
Stem and progenitor cells presumably help repair damaged lung, but identification of such cells remains problematic. The large surface area, numerous branches, and folded topography suggest lung harbors several stem or progenitor cell types. In trachea and bronchi, certain BCs and mucous-gland duct cells are believed to be stem/progenitor cells. Clara-like cells and type II pneumocytes are also thought to function as stem/progenitor cells in bronchioles and alveoli, respectively. Another population of stem/progenitor cells apparently lies at the bronchoalveolar duct junction (
Kim et al., 2005). They have been proposed to function as bipotential precursors of both the SP-C- and CC10-expressing cell lineages.
It has recently been reported that bone marrow-derived mesenchymal stem cells can differentiate into airway epithelial cells and alveolar type I pneumocytes, particularly post-injury. By contrast, in vitro cell culture indicates Syrian hamster fetal lung epithelial M3E3/C3 cells differentiate into Clara cells and type II pneumocytes under different culture conditions. Whether CCSP-expressing cells with pre-Clara cell phenotypes are stem cells for the entire respiratory tract remains to be determined. In addition, the concept of a pluripotent stem cell for the whole lung needs to be further investigated due to the great differences between identified stem cell or progenitor candidates in proximal bronchi and distal alveoli. Recently, we discovered lung contains cells with stem or progenitor characteristics that can be FACS sorted from adult rat and mouse lung and which are relatively apoptosis-resistant and perhaps responsible for post-injury alveolar repopulation. Another such population sorted as “side cells” on FACS may repopulate several tissues including bone marrow.
ASM derives from at least two progenitor populations: one comes from the lung periphery and arises from
Fgf10-expressing cells in subepithelial mesenchyme. By virtue of FGF10 expression, these cells first help mediate epithelial branching; however, as the airway elongates into peripheral mesenchyme, these progenitors remain to lie along the more proximal stalk of the distal bud. Here they differentiate into ASM, most probably under paracrine induction of BMP4 and Sonic hedgehog from the adjacent epithelium (
DeLanghe et al., 2006). The second ASM progenitor population arises around the proximal large airways (
Shan et al., 2008) and appears to meet with the distally-derived counterparts beyond major lobar and segmental branches. It is speculated that whilst size of such ASM progenitor populations are determined during embryonic airway branching, they may nevertheless determine susceptibility to later BPD and asthma. Moreover, maternal smoking may dysregulate ASM progenitors and their progeny via the cholinergic-agonist, nicotine.
5.7. Potential strategies to protect lung progenitors
Both FGF7 and inosine treatment ameliorate DNA damage in AECs, as well as enhancing mitochondrial protection and the ability of AEC to migrate and repair in an
in vitro scratch assay (
Buckley et al., 1997). FGF7 has also been evaluated by others
in vivo as a treatment to enhance resistance to alveolar injury in animal models (
Plantier et al., 2007;
Ray et al., 2003). Also, FGF10 has a protective effect against lung injury and fibrosis (
Gupte et al., 2009). We have also shown that inosine has protective properties against oxygen injury, including glutathione repletion, mitochondrial protection, decreased apoptosis, and increased VEGF expression (
Buckley et al., 2005). Thus, it appears that protection or enhancement of alveolar progenitor cell function may be a viable therapeutic option that could possibly be evaluated in clinical trials of lung progenitor cell protection using small molecules such as inosine or FGF7 or FGF10.